Impact of reproductive status and age on response of depressed women to cognitive therapy

Anna R. Brandon, Abu Minhajuddin, Michael E. Thase, Robin B. Jarrett

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: Previous research suggests that reproductive hormones are potential affective modulators in mood disorders and may influence response to antidepressant medications. To our knowledge, there are no data on relationships between hormonal status and response to psychotherapy for recurrent major depressive disorder (MDD). Methods: At two sites, female outpatients (n=353), aged 18-70, with recurrent MDD received 12-14 weeks of cognitive therapy (CT). Menopausal status and age were based on self-report. In the parent study, nonresponse to therapy was defined as persistence of a major depressive episode (MDE) as defined by the DSM-IV or a final Hamilton Rating Scale for Depression-17-Item (HRSD17) score of ≥ 12 or both. More traditional definitions of response (at least a 50% reduction in pretreatment HRSD17) and remission (a final HRSD17 ≤ 6) were also examined. Results: Controlling for pretreatment HRSD17 scores, there were no significant differences found in the rates of response to CT or symptom status among premenopausal, perimenopausal, and postmenopausal women. Conclusions: We found no support for the hypotheses that response to CT or the rates of change in depressive symptoms are moderated by reproductive status. The findings, however, are limited by the absence of early follicular phase serum sampling/analysis to estimate hormone levels and the reliance on self-report to establish menopausal status. These data motivate a full investigation of the effects of reproductive status on response to psychosocial interventions.

Original languageEnglish (US)
Pages (from-to)58-66
Number of pages9
JournalJournal of Women's Health
Volume22
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Cognitive Therapy
Depression
Major Depressive Disorder
Self Report
Hormones
Neurobehavioral Manifestations
Follicular Phase
Mood Disorders
Psychotherapy
Diagnostic and Statistical Manual of Mental Disorders
Antidepressive Agents
Outpatients
Serum
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Impact of reproductive status and age on response of depressed women to cognitive therapy. / Brandon, Anna R.; Minhajuddin, Abu; Thase, Michael E.; Jarrett, Robin B.

In: Journal of Women's Health, Vol. 22, No. 1, 01.01.2013, p. 58-66.

Research output: Contribution to journalArticle

@article{19d14b34df364505ae44c0590d6491e0,
title = "Impact of reproductive status and age on response of depressed women to cognitive therapy",
abstract = "Objective: Previous research suggests that reproductive hormones are potential affective modulators in mood disorders and may influence response to antidepressant medications. To our knowledge, there are no data on relationships between hormonal status and response to psychotherapy for recurrent major depressive disorder (MDD). Methods: At two sites, female outpatients (n=353), aged 18-70, with recurrent MDD received 12-14 weeks of cognitive therapy (CT). Menopausal status and age were based on self-report. In the parent study, nonresponse to therapy was defined as persistence of a major depressive episode (MDE) as defined by the DSM-IV or a final Hamilton Rating Scale for Depression-17-Item (HRSD17) score of ≥ 12 or both. More traditional definitions of response (at least a 50{\%} reduction in pretreatment HRSD17) and remission (a final HRSD17 ≤ 6) were also examined. Results: Controlling for pretreatment HRSD17 scores, there were no significant differences found in the rates of response to CT or symptom status among premenopausal, perimenopausal, and postmenopausal women. Conclusions: We found no support for the hypotheses that response to CT or the rates of change in depressive symptoms are moderated by reproductive status. The findings, however, are limited by the absence of early follicular phase serum sampling/analysis to estimate hormone levels and the reliance on self-report to establish menopausal status. These data motivate a full investigation of the effects of reproductive status on response to psychosocial interventions.",
author = "Brandon, {Anna R.} and Abu Minhajuddin and Thase, {Michael E.} and Jarrett, {Robin B.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1089/jwh.2011.3427",
language = "English (US)",
volume = "22",
pages = "58--66",
journal = "Journal of Women's Health",
issn = "1540-9996",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Impact of reproductive status and age on response of depressed women to cognitive therapy

AU - Brandon, Anna R.

AU - Minhajuddin, Abu

AU - Thase, Michael E.

AU - Jarrett, Robin B.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Objective: Previous research suggests that reproductive hormones are potential affective modulators in mood disorders and may influence response to antidepressant medications. To our knowledge, there are no data on relationships between hormonal status and response to psychotherapy for recurrent major depressive disorder (MDD). Methods: At two sites, female outpatients (n=353), aged 18-70, with recurrent MDD received 12-14 weeks of cognitive therapy (CT). Menopausal status and age were based on self-report. In the parent study, nonresponse to therapy was defined as persistence of a major depressive episode (MDE) as defined by the DSM-IV or a final Hamilton Rating Scale for Depression-17-Item (HRSD17) score of ≥ 12 or both. More traditional definitions of response (at least a 50% reduction in pretreatment HRSD17) and remission (a final HRSD17 ≤ 6) were also examined. Results: Controlling for pretreatment HRSD17 scores, there were no significant differences found in the rates of response to CT or symptom status among premenopausal, perimenopausal, and postmenopausal women. Conclusions: We found no support for the hypotheses that response to CT or the rates of change in depressive symptoms are moderated by reproductive status. The findings, however, are limited by the absence of early follicular phase serum sampling/analysis to estimate hormone levels and the reliance on self-report to establish menopausal status. These data motivate a full investigation of the effects of reproductive status on response to psychosocial interventions.

AB - Objective: Previous research suggests that reproductive hormones are potential affective modulators in mood disorders and may influence response to antidepressant medications. To our knowledge, there are no data on relationships between hormonal status and response to psychotherapy for recurrent major depressive disorder (MDD). Methods: At two sites, female outpatients (n=353), aged 18-70, with recurrent MDD received 12-14 weeks of cognitive therapy (CT). Menopausal status and age were based on self-report. In the parent study, nonresponse to therapy was defined as persistence of a major depressive episode (MDE) as defined by the DSM-IV or a final Hamilton Rating Scale for Depression-17-Item (HRSD17) score of ≥ 12 or both. More traditional definitions of response (at least a 50% reduction in pretreatment HRSD17) and remission (a final HRSD17 ≤ 6) were also examined. Results: Controlling for pretreatment HRSD17 scores, there were no significant differences found in the rates of response to CT or symptom status among premenopausal, perimenopausal, and postmenopausal women. Conclusions: We found no support for the hypotheses that response to CT or the rates of change in depressive symptoms are moderated by reproductive status. The findings, however, are limited by the absence of early follicular phase serum sampling/analysis to estimate hormone levels and the reliance on self-report to establish menopausal status. These data motivate a full investigation of the effects of reproductive status on response to psychosocial interventions.

UR - http://www.scopus.com/inward/record.url?scp=84872304385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872304385&partnerID=8YFLogxK

U2 - 10.1089/jwh.2011.3427

DO - 10.1089/jwh.2011.3427

M3 - Article

VL - 22

SP - 58

EP - 66

JO - Journal of Women's Health

JF - Journal of Women's Health

SN - 1540-9996

IS - 1

ER -